Browsing "Comunicações em Eventos - LIM/24" by Title
Showing results 337 to 356 of 577
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 2021 | National prevalence of oral HPV infection in vaccinated and unvaccinated young adults in Brazil | KOPS, Natalia Luiza; COMERLATO, Juliana; BANDEIRA, Isabel; BESSEL, Marina; MARANHAO, Ana Goretti Kalume; VILLA, Luisa Lina; MOTA, Giana; SOUZA, Flavia Moreno Alves de; PEREIRA, Gerson Fernando Mendes; WENDLAND, Eliana |
| 2022 | Navigation of patients with locally advanced head and neck squamous cell carcinoma during cisplatin-based chemoradiation: A cohort study. | CASTRO, Gilberto De; SOUZA, Priscila Rangel De; NUNES, Lenira Corsi Ruggiero; SOUZA, Rosilene Josefa; DIAS, Tamara Aparecida Vieira; REIS, Nathalia Dos; GOES, Samira S.; MORAVIA, Renata Alvim; MOREIRA, Paulo Thadeu Fantinato; LOPEZ, Rossana Veronica Mendoza, et al |
| 2017 | Near Infrared Fluorescence In-Vivo Imaging of Non-Hodgkin Lymphoma Using Cy7-Bevacizumab | CAMACHO, Ximena; PERRONI, Carolina; JUNQUEIRA, Mara de Souza; FERNANDEZ, Marcelo; BUSTOS, Silvina; BUCHPIGUEL, Carlos; CHAMMAS, Roger; GAMBINI, Juan Pablo; CABRAL, Pablo; RIVA, Eloisa |
| 2018 | Neoadjuvant chemotherapy and radical surgery versus chemorradiation for stage IB2, IIA2 e IIB cervical cancer: A randomized controlled trial | REIS FILHO, P. T. F.; ANDRADE, J. M.; BATISTA, M. P.; SOUSA, C. B.; OLIVEIRA, T. H. G. F.; ARRUDA, G. V.; OLIVEIRA, T. M. G.; GABRIELLI, F.; GENTA, M. L. N. D.; POVEDA, A. M., et al |
| 2019 | NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY VERSUS CHEMORADIATION FOR STAGE IB2, IIA2 AND IIB CERVICAL CANCER: AN OPEN-LABEL, PHASE III, RANDOMIZED CONTROLLED TRIAL | REIS FILHO, P. T. F.; BATISTA, M. P.; SOUSA, C. B.; OLIVIERA, T. H. G. F.; ARRUDA, G. V.; ANDRADE, J. M.; DIZ, M. Del Pilar Estevez; REIS, F. J. C. D. |
| 2015 | Neoadjuvant chemotherapy for elderly breast cancer patients | MATUTINO, A. Reis Brandao; LIMA, J. M. Silva; SILVA, S. Brito; BOAS, M. Vilas; STEPHAN, B. Oliveira; VAIRSBERG, V. Van; FRAILE, N. Moreno Perez; BARROSO-SOUSA, R.; MANO, M. Senna |
| 2018 | Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation with cisplatin in locally advanced cervical cancer: A phase II, prospective, randomized, trial | SILVA, Samantha; BONADIO, Renata R. C. Colombo; GABRIELLI, Flavia; ARANHA, Andrea Souza; GENTA, Maria Luiza; MIRANDA, Vanessa Costa; FREITAS, Daniela; FILHO, Elias Abdo; FERREIRA, Patricia Alves De Oliveira; KALIL, Karime, et al |
| 2013 | Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients not candidates for optimal primary surgery: Safety and effectivenes | MIRANDA, Vanessa Costa; FEDE, Angelo Bezerra de Sousa; ANJOS, Carlos Henrique Dos; SILVA, Juliana Ribeiro da; SANCHEZ, Fernando Barbosa; BESSA, Lyvia Rodrigues da Silva; CARVALHO, Jesus Paula; ABDO FILHO, Elias; FREITAS, Daniela; BARROS, Laryssa Almeida Borges de, et al |
| 2022 | NEPTUNE China Cohort: First-Line Durvalumab plus Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC | CHENG, Y.; ZHOU, Q.; HAN, B.; FAN, Y.; SHAN, L.; CHANG, J.; SUN, S.; FANG, J.; CHEN, Y.; SUN, J., et al |
| 2021 | Neurotuberculosis in a patient with Ulcerative Colitis using adalimumab for a long period in Brazil | FACANALI, M.; FACANALI, C. Bortolozzo Graciolli; BOARINI, L. Rodrigues; RIBEIRO, A. Vaz Safatle; SOBRADO, C. W. |
| 2022 | Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648. | CHAU, Ian; AJANI, Jaffer A.; DOKI, Yuichiro; XU, Jianming; WYRWICZ, Lucjan; MOTOYAMA, Satoru; OGATA, Takashi; KAWAKAMI, Hisato; HSU, Chih-Hung; ADENIS, Antoine, et al |
| 2023 | Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): 29-month (mo) follow-up from CheckMate 648 | GREIL, R.; KATO, K.; AJANI, J.; DOKI, Y.; XU, J.; WYRWICZ, L.; MOTOYAMA, S.; OGATA, T.; KAWAKAMI, H.; HSU, C. -H, et al |
| 2023 | Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): 29-month (mo) follow-up from CheckMate 648. | KATO, Ken; AJANI, Jaffer A.; DOKI, Yuichiro; XU, Jianming; WYRWICZ, Lucjan; MOTOYAMA, Satoru; OGATA, Takashi; KAWAKAMI, Hisato; HSU, Chih-Hung; ADENIS, Antoine, et al |
| 2022 | Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): Expanded efficacy and safety analyses from CheckMate 648 | CHAU, I.; AJANI, J.; DOKI, Y.; XU, J.; WYRWICZ, L.; MOTOYAMA, S.; OGATA, T.; KAWAKAMI, H.; HSU, C.; ADENIS, A., et al |
| 2021 | Nivolumab (NIVO) plus chemotherapy (chemo) or NIVO plus ipilimumab (IPI) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): first report of the CheckMate 648 study | GREIL, R.; CHAU, I; DOKI, Y.; AJANI, J. A.; XU, J.; WYRWICZ, L.; MOTOYAMA, S.; OGATA, T.; KAWAKAMI, H.; HSU, C. -H, et al |
| 2021 | Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study. | CHAU, Ian; DOKI, Yuichiro; AJANI, Jaffer A.; XU, Jianming; WYRWICZ, Lucjan; MOTOYAMA, Satoru; OGATA, Takashi; KAWAKAMI, Hisato; HSU, Chih-Hung; ADENIS, Antoine, et al |
| 2015 | OBSERVATION VERSUS SURGICAL RESECTION IN PATIENTS WITH RECTAL CANCER WHO ACHIEVED COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL (NCT02052921). | NAHAS, S.; NAHAS, C.; RIBEIRO JUNIOR, U.; MARQUES, C. Sparapan; COTTI, G. C.; IMPERIALE, A.; ORTEGA, C.; AZAMBUJA, R.; CHEN, A.; HOFF, P., et al |
| 2020 | ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer | LEYVRAZ, S.; YANG, J. C-H.; CASALI, P. G.; CASTRO, G.; KIM, E. S.; LASSEN, U. N.; LOPEZ-RIOS, F.; PENAULT-LLORCA, F.; PAPPO, A.; RUDZINSKI, E. R., et al |
| 2019 | ONCOLOGICAL AND SURVIVAL OUTCOMES OF IMMEDIATE NONOPERATIVE MANAGEMENT AFTER CHEMORADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER: APPRAISAL OF CLINICAL COMPLETE RESPONSE. | COTTI, G. C.; PANDINI, R. V.; BRAGHIROLI, O. Freitas Melro; NAHAS, C.; IMPERIALE, A. R.; MARQUES, C. F.; RIBEIRO JUNIOR, U.; NAHAS, S.; BUSTAMANTE, L.; AZAMBUJA, R., et al |
| 2021 | ONCOLOGICAL OUTCOMES IN UNCLASSIFIED RENAL CELL CARCINOMA | SAWCZYN, Guilherme; RODRIGUES, Gilberto; PEREIRA, Maykon; CARDILLI, Leonardo; CARVALHO, Paulo Afonso; GALLUCCI, Fabio; SARKIS, Alvaro; NAHAS, William; CORDEIRO, Mauricio |